• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAMTS-4 和 ADAMTS-5:骨关节炎中的关键酶。

ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.

机构信息

Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Cell Biochem. 2011 Dec;112(12):3507-14. doi: 10.1002/jcb.23298.

DOI:10.1002/jcb.23298
PMID:21815191
Abstract

Osteoarthritis (OA) is a progressive disease of the joints characterized by degradation of articular cartilage. Although disease initiation may be multi-factorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction. A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue. Aggrecanase-mediated aggrecan degradation is a significant event in early stage OA. The relative contribution of individual ADAMTS-4 and ADAMTS-5 proteinases to cartilage destruction during OA has not been resolved completely. This review reveals that both ADAMTS-4/ADAMTS-5 are responsible for aggrecan degradation in a human model of OA, and is expected to list down the rational strategies which are being focussed for therapeutic intervention in OA.

摘要

骨关节炎(OA)是一种以关节软骨退化为特征的进行性疾病。尽管疾病的发生可能是多因素的,但软骨的破坏似乎是由于细胞外基质的失控性蛋白水解引起的。软骨细胞外基质的主要成分是聚集蛋白聚糖,它赋予组织抗压能力。聚集蛋白聚糖酶介导的聚集蛋白聚糖降解是早期 OA 的一个重要事件。ADAMTS-4 和 ADAMTS-5 蛋白酶在 OA 中对软骨破坏的相对贡献尚未完全解决。这篇综述表明,ADAMTS-4/ADAMTS-5 均参与了 OA 患者的聚集蛋白聚糖降解,有望为 OA 的治疗干预列出正在关注的合理策略。

相似文献

1
ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.ADAMTS-4 和 ADAMTS-5:骨关节炎中的关键酶。
J Cell Biochem. 2011 Dec;112(12):3507-14. doi: 10.1002/jcb.23298.
2
Aggrecanase and aggrecan degradation in osteoarthritis: a review.骨关节炎中的聚集蛋白聚糖酶与聚集蛋白聚糖降解:综述
J Int Med Res. 2008 Nov-Dec;36(6):1149-60. doi: 10.1177/147323000803600601.
3
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.人关节软骨外植体中的聚集蛋白聚糖降解由ADAMTS - 4和ADAMTS - 5共同介导。
Arthritis Rheum. 2007 Feb;56(2):575-85. doi: 10.1002/art.22334.
4
The cleavage of biglycan by aggrecanases.聚糖酶对双糖链蛋白聚糖的切割
Osteoarthritis Cartilage. 2006 Nov;14(11):1147-54. doi: 10.1016/j.joca.2006.05.014. Epub 2006 Jun 30.
5
[Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].含血小板反应蛋白基序的解聚素和金属蛋白酶4及5在骨关节炎中的研究进展
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Sep;27(9):1080-4.
6
Aggrecanases in the human synovial fluid at different stages of osteoarthritis.人滑液中不同阶段骨关节炎的聚集蛋白聚糖酶。
Clin Rheumatol. 2013 Jun;32(6):797-803. doi: 10.1007/s10067-013-2171-0. Epub 2013 Jan 31.
7
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.在骨关节炎小鼠模型中,删除活性ADAMTS5可防止软骨降解。
Nature. 2005 Mar 31;434(7033):644-8. doi: 10.1038/nature03369.
8
The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.骨关节炎中ADAMTS4和ADAMTS5聚糖酶的调节:综述
Clin Exp Rheumatol. 2008 Jan-Feb;26(1):139-45.
9
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.聚硫酸戊聚糖钙是一种多方面的聚集蛋白聚糖酶外位点抑制剂。
FASEB J. 2008 Oct;22(10):3515-24. doi: 10.1096/fj.08-112680. Epub 2008 Jul 16.
10
The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.蛋白酶抑制剂对牛全层软骨外植体中骨关节炎相关生物标志物诱导的影响。
PLoS One. 2015 Apr 24;10(4):e0122700. doi: 10.1371/journal.pone.0122700. eCollection 2015.

引用本文的文献

1
Unveiling Conserved Molecular Pathways of Intramuscular Fat Deposition and Shared Metabolic Processes in Semitendinosus Muscle of Hereford, Holstein, and Limousine Cattle via RNA-Seq Analysis.通过RNA测序分析揭示赫里福德牛、荷斯坦牛和利木赞牛半腱肌中肌内脂肪沉积的保守分子途径和共享代谢过程
Genes (Basel). 2025 Aug 21;16(8):984. doi: 10.3390/genes16080984.
2
Molecular Biology of ACL Graft Healing: Early Mechanical Loading Perspective.前交叉韧带移植物愈合的分子生物学:早期机械负荷视角
Orthop Rev (Pavia). 2025 Jul 26;17:140716. doi: 10.52965/001c.140716. eCollection 2025.
3
Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders.
骨科疾病中的核酸适配体:治疗骨病的潜在治疗剂。
Bone Res. 2025 Jul 24;13(1):71. doi: 10.1038/s41413-025-00447-8.
4
SIRT1 antisense long noncoding RNA attenuates interleukin-1β-induced osteoarthritic gene expression in human chondrocytes through its mRNA interaction.SIRT1反义长链非编码RNA通过与mRNA相互作用减弱白细胞介素-1β诱导的人软骨细胞中骨关节炎相关基因的表达。
Sci Rep. 2025 Jul 2;15(1):23338. doi: 10.1038/s41598-025-06565-x.
5
A novel mechanosensitive stress test in individuals following anterior cruciate ligament reconstruction: A pilot study.一项针对前交叉韧带重建术后个体的新型机械敏感应力测试:一项初步研究。
Osteoarthr Cartil Open. 2025 May 9;7(3):100619. doi: 10.1016/j.ocarto.2025.100619. eCollection 2025 Sep.
6
Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers.基于抗体和适配体的骨关节炎治疗方法:抗体的应用及适配体的前景。
Mol Ther Nucleic Acids. 2025 May 5;36(2):102552. doi: 10.1016/j.omtn.2025.102552. eCollection 2025 Jun 10.
7
In vitro model of equine cartilage degradation; using cartilage pellets differentiated from bone marrow-derived mesenchymal stem cells.马软骨降解的体外模型;使用从骨髓间充质干细胞分化而来的软骨微珠。
In Vitro Cell Dev Biol Anim. 2025 May 27. doi: 10.1007/s11626-025-01049-8.
8
Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis.组织蛋白酶K抑制剂作为治疗骨关节炎的潜在药物
Int J Mol Sci. 2025 Mar 22;26(7):2896. doi: 10.3390/ijms26072896.
9
Rethinking Osteoarthritis Management: Synergistic Effects of Chronoexercise, Circadian Rhythm, and Chondroprotective Agents.重新思考骨关节炎的管理:时间运动、昼夜节律和软骨保护剂的协同作用
Biomedicines. 2025 Mar 1;13(3):598. doi: 10.3390/biomedicines13030598.
10
Isolation, Characterization, and In Vitro Cell Studies of Plant-Based Exosome-like Nanovesicles for Treatment of Early Osteoarthritis.用于治疗早期骨关节炎的植物源外泌体样纳米囊泡的分离、表征及体外细胞研究
Int J Mol Sci. 2025 Feb 28;26(5):2211. doi: 10.3390/ijms26052211.